Genetic Analysis AS (XSAT:GEAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
0.6400
-0.0100 (-1.54%)
At close: Jun 11, 2026

Genetic Analysis AS Statistics

Total Valuation

XSAT:GEAN has a market cap or net worth of SEK 44.30 million. The enterprise value is 32.97 million.

Market Cap44.30M
Enterprise Value 32.97M

Important Dates

The last earnings date was Thursday, May 28, 2026.

Earnings Date May 28, 2026
Ex-Dividend Date n/a

Share Statistics

XSAT:GEAN has 69.09 million shares outstanding. The number of shares has increased by 46.42% in one year.

Current Share Class 69.09M
Shares Outstanding 69.09M
Shares Change (YoY) +46.42%
Shares Change (QoQ) n/a
Owned by Insiders (%) 14.26%
Owned by Institutions (%) 15.04%
Float 19.09M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.10
PB Ratio 2.02
P/TBV Ratio 10.20
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.53
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.39.

Current Ratio 1.53
Quick Ratio 1.46
Debt / Equity 0.39
Debt / EBITDA n/a
Debt / FCF -6.21
Interest Coverage -8.74

Financial Efficiency

Return on equity (ROE) is -56.49% and return on invested capital (ROIC) is -23.99%.

Return on Equity (ROE) -56.49%
Return on Assets (ROA) -15.66%
Return on Invested Capital (ROIC) -23.99%
Return on Capital Employed (ROCE) -35.09%
Weighted Average Cost of Capital (WACC) 15.01%
Revenue Per Employee 1.17M
Profits Per Employee -620,546
Employee Count18
Asset Turnover 0.49
Inventory Turnover 5.86

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -34.69% in the last 52 weeks. The beta is 2.08, so XSAT:GEAN's price volatility has been higher than the market average.

Beta (5Y) 2.08
52-Week Price Change -34.69%
50-Day Moving Average 0.65
200-Day Moving Average 0.74
Relative Strength Index (RSI) 47.23
Average Volume (20 Days) 24,606

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, XSAT:GEAN had revenue of SEK 21.06 million and -11.17 million in losses. Loss per share was -0.17.

Revenue21.06M
Gross Profit 15.84M
Operating Income -10.70M
Pretax Income -11.17M
Net Income -11.17M
EBITDA -10.60M
EBIT -10.70M
Loss Per Share -0.17
Full Income Statement

Balance Sheet

The company has 19.57 million in cash and 8.52 million in debt, with a net cash position of 11.05 million or 0.16 per share.

Cash & Cash Equivalents 19.57M
Total Debt 8.52M
Net Cash 11.05M
Net Cash Per Share 0.16
Equity (Book Value) 21.96M
Book Value Per Share 0.32
Working Capital 9.28M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.03 million and capital expenditures -343,958, giving a free cash flow of -1.37 million.

Operating Cash Flow -1.03M
Capital Expenditures -343,958
Depreciation & Amortization 99,115
Net Borrowing 1.17M
Free Cash Flow -1.37M
FCF Per Share -0.02
Full Cash Flow Statement

Margins

Gross margin is 75.23%, with operating and profit margins of -50.81% and -53.05%.

Gross Margin 75.23%
Operating Margin -50.81%
Pretax Margin -53.05%
Profit Margin -53.05%
EBITDA Margin -50.34%
EBIT Margin -50.81%
FCF Margin n/a

Dividends & Yields

XSAT:GEAN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -46.42%
Shareholder Yield -46.42%
Earnings Yield -25.21%
FCF Yield -3.10%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

XSAT:GEAN has an Altman Z-Score of 0.27 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.27
Piotroski F-Score 3